ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday
New York, Jan 25, 2026, 05:38 EST — Market closed ImmunityBio, Inc. (IBRX) shares closed Friday down 12.1% at $6.45, having traded as high as $7.88 and as low as $6.43 amid heavy volume. (Yahoo Finance) This move is significant since the stock’s been riding momentum, but Friday’s pullback hands control back to next week’s data releases. Monday’s open will…